TLP
Tri Locum Partners’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Buy |
2,046,846
+985,838
| +93% | +$16.5M | 10.41% | 1 |
|
|
2025
Q1 | $16.3M | Sell |
1,061,008
-1,362,108
| -56% | -$20.9M | 8.37% | 4 |
|
|
2024
Q4 | $53.4M | Sell |
2,423,116
-332,621
| -12% | -$7.33M | 11.06% | 1 |
|
|
2024
Q3 | $49.7M | Buy |
2,755,737
+205,430
| +8% | +$3.7M | 11.9% | 2 |
|
|
2024
Q2 | $41.4M | Buy |
2,550,307
+334,119
| +15% | +$5.43M | 10.48% | 1 |
|
|
2024
Q1 | $31.3M | Buy |
2,216,188
+421,853
| +24% | +$5.95M | 10.84% | 1 |
|
|
2023
Q4 | $18.7M | Sell |
1,794,335
-838,558
| -32% | -$8.75M | 8.56% | 2 |
|
|
2023
Q3 | $26.9M | Buy |
2,632,893
+1,527,123
| +138% | +$15.6M | 8.59% | 2 |
|
|
2023
Q2 | $8.33M | Buy |
1,105,770
+93,397
| +9% | +$703K | 3.09% | 11 |
|
|
2023
Q1 | $8.96M | Buy |
+1,012,373
| New | +$8.96M | 2.73% | 14 |
|
|
2022
Q4 | – | Sell |
-683,613
| Closed | -$5.52M | – | 86 |
|
|
2022
Q3 | $5.52M | Buy |
+683,613
| New | +$5.52M | 1.51% | 25 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 39 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 36 |
|